Primary leiomyosarcoma of bone: a clinicopathologic and immunohistochemical study of 142 cases.

IF 2.9 Q1 PATHOLOGY
Elena Bellan, Alberto Righi, Marco Gambarotti, Stefania Benini, Dino Gibertoni, Marilena Cesari, Giuseppe Bianchi, Piero Picci, Angelo P Dei Tos, Marta Sbaraglia
{"title":"Primary leiomyosarcoma of bone: a clinicopathologic and immunohistochemical study of 142 cases.","authors":"Elena Bellan, Alberto Righi, Marco Gambarotti, Stefania Benini, Dino Gibertoni, Marilena Cesari, Giuseppe Bianchi, Piero Picci, Angelo P Dei Tos, Marta Sbaraglia","doi":"10.32074/1591-951X-N1251","DOIUrl":null,"url":null,"abstract":"<p><p>Leiomyosarcoma is a rare malignant mesenchymal tumor characterized by smooth muscle differentiation. It typically arises in both visceral and somatic soft tissues, while involvement of bone being exceptionally uncommon. Although primary leiomyosarcoma of bone has been a subject of ongoing debate, the advent of immunohistochemistry has reduced the misclassification of other sarcomas, such as fibrosarcoma and undifferentiated pleomorphic sarcoma, facilitating the accurate identification of true primary LMSB cases. To date, just over 200 well-documented LMSB cases have been published in English-language literature. Despite this, understanding of its clinical behaviour and factors influencing patient outcomes remains limited. In this study, we present the clinical, pathological, and immunohistochemical findings from 142 cases of primary bone leiomyosarcoma including extended follow-up data.</p>","PeriodicalId":45893,"journal":{"name":"PATHOLOGICA","volume":"117 3","pages":"288-295"},"PeriodicalIF":2.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12236143/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PATHOLOGICA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32074/1591-951X-N1251","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Leiomyosarcoma is a rare malignant mesenchymal tumor characterized by smooth muscle differentiation. It typically arises in both visceral and somatic soft tissues, while involvement of bone being exceptionally uncommon. Although primary leiomyosarcoma of bone has been a subject of ongoing debate, the advent of immunohistochemistry has reduced the misclassification of other sarcomas, such as fibrosarcoma and undifferentiated pleomorphic sarcoma, facilitating the accurate identification of true primary LMSB cases. To date, just over 200 well-documented LMSB cases have been published in English-language literature. Despite this, understanding of its clinical behaviour and factors influencing patient outcomes remains limited. In this study, we present the clinical, pathological, and immunohistochemical findings from 142 cases of primary bone leiomyosarcoma including extended follow-up data.

Abstract Image

Abstract Image

Abstract Image

142例原发性骨平滑肌肉瘤的临床病理及免疫组织化学分析。
平滑肌肉瘤是一种罕见的恶性间质肿瘤,以平滑肌分化为特征。它通常发生在内脏和躯体软组织,而累及骨骼是非常罕见的。尽管原发性骨平滑肌肉瘤一直是争论的主题,但免疫组织化学的出现减少了其他肉瘤的错误分类,如纤维肉瘤和未分化多形性肉瘤,有助于准确识别真正的原发性LMSB病例。迄今为止,在英语文献中发表的LMSB病例仅超过200例。尽管如此,对其临床行为和影响患者预后的因素的了解仍然有限。在这项研究中,我们报告了142例原发性骨平滑肌肉瘤的临床、病理和免疫组织化学结果,包括延长的随访数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
PATHOLOGICA
PATHOLOGICA PATHOLOGY-
CiteScore
5.90
自引率
5.70%
发文量
108
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信